Kiralee hayashi biography of mahatma gandhi
•
Keywords
Antibody-drug conjugates, cancer treatment, novel anticancer therapies, combination regimensAbbreviations
| ABVD: | doxorubicin-bleomycin-vinblastine-dacarbazine |
| ADCs: | antibody-drug conjugates |
| AEs: | adverse events |
| ALL: | acute lymphoblastic leukemia |
| AML: | acute myeloid leukemia |
| AR: | anetumab ravtansine |
| AVD: | doxorubicin-vinblastine-dacarbazine |
| BC: | breast cancer |
| BM: | belantamab mafodotin |
| BV: | brentuximab vedotin |
| CHOP: | cyclophosphamide-doxorubicin-vincristine-prednisone |
| DA: | daunorubicin and cytarabine |
| Dato-DXd: | datopotamab deruxtecan |
| Depatux-M: | depatuxizumab mafodotin |
| DLBCL: | diffuse large B-cell lymphoma |
| EGFR: | epidermal growth factor receptor |
| EV: | enfortumab vedotin |
| FDA: | Food and Drug Administration |
| FRα: | folate receptor alpha |
| G3: | grade 3 |
| GO: | gemtuzumab ozogamicin |
| HER2: | human epidermal growth factor receptor 2 |
| HL: | Hodgkin lymphoma |